| 1 | desmosome organization (GO:0002934) | 6.66605125 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.17738113 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 5.17738113 |
| 4 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.08917483 |
| 5 | protein maturation by protein folding (GO:0022417) | 4.90630199 |
| 6 | hemidesmosome assembly (GO:0031581) | 4.82190156 |
| 7 | artery smooth muscle contraction (GO:0014824) | 4.73057287 |
| 8 | establishment of integrated proviral latency (GO:0075713) | 4.35555898 |
| 9 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.26849526 |
| 10 | interferon-gamma secretion (GO:0072643) | 4.26183941 |
| 11 | establishment of viral latency (GO:0019043) | 4.21037129 |
| 12 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.14487012 |
| 13 | tonic smooth muscle contraction (GO:0014820) | 4.01126940 |
| 14 | nuclear envelope reassembly (GO:0031468) | 3.96848253 |
| 15 | mitotic nuclear envelope reassembly (GO:0007084) | 3.96848253 |
| 16 | prostaglandin biosynthetic process (GO:0001516) | 3.91551759 |
| 17 | prostanoid biosynthetic process (GO:0046457) | 3.91551759 |
| 18 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.89727787 |
| 19 | positive regulation of actin filament depolymerization (GO:0030836) | 3.84332242 |
| 20 | hepatocyte apoptotic process (GO:0097284) | 3.80929434 |
| 21 | regulation of water loss via skin (GO:0033561) | 3.78549193 |
| 22 | xenobiotic catabolic process (GO:0042178) | 3.68803481 |
| 23 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.62179545 |
| 24 | regulation of metalloenzyme activity (GO:0048552) | 3.58114813 |
| 25 | proteasome assembly (GO:0043248) | 3.57518217 |
| 26 | GDP-mannose metabolic process (GO:0019673) | 3.52334744 |
| 27 | establishment of skin barrier (GO:0061436) | 3.49135156 |
| 28 | protein retention in ER lumen (GO:0006621) | 3.48228456 |
| 29 | membrane raft organization (GO:0031579) | 3.44175418 |
| 30 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.42122378 |
| 31 | NADH metabolic process (GO:0006734) | 3.36815417 |
| 32 | daunorubicin metabolic process (GO:0044597) | 3.36811189 |
| 33 | polyketide metabolic process (GO:0030638) | 3.36811189 |
| 34 | doxorubicin metabolic process (GO:0044598) | 3.36811189 |
| 35 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.27854727 |
| 36 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.27496354 |
| 37 | membrane budding (GO:0006900) | 3.26133799 |
| 38 | muscle cell migration (GO:0014812) | 3.25321778 |
| 39 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.23377625 |
| 40 | galactose catabolic process (GO:0019388) | 3.18767152 |
| 41 | glucose 6-phosphate metabolic process (GO:0051156) | 3.17175794 |
| 42 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.16378192 |
| 43 | prostanoid metabolic process (GO:0006692) | 3.14512379 |
| 44 | prostaglandin metabolic process (GO:0006693) | 3.14512379 |
| 45 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.13970698 |
| 46 | keratinocyte development (GO:0003334) | 3.13802824 |
| 47 | negative regulation of kidney development (GO:0090185) | 3.10648006 |
| 48 | positive regulation of pseudopodium assembly (GO:0031274) | 3.10262577 |
| 49 | positive regulation of epidermis development (GO:0045684) | 3.08350270 |
| 50 | ribosome assembly (GO:0042255) | 3.05109199 |
| 51 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.02384824 |
| 52 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.00025116 |
| 53 | mesonephros development (GO:0001823) | 2.99139823 |
| 54 | pentose-phosphate shunt (GO:0006098) | 2.95468254 |
| 55 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.93930633 |
| 56 | glucose catabolic process (GO:0006007) | 2.93334207 |
| 57 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.92632780 |
| 58 | multicellular organismal water homeostasis (GO:0050891) | 2.90439317 |
| 59 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.90180254 |
| 60 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.87401503 |
| 61 | macrophage chemotaxis (GO:0048246) | 2.85564764 |
| 62 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.85512376 |
| 63 | hepatocyte differentiation (GO:0070365) | 2.85098698 |
| 64 | inositol phosphate-mediated signaling (GO:0048016) | 2.83673129 |
| 65 | diterpenoid biosynthetic process (GO:0016102) | 2.81027430 |
| 66 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.80390822 |
| 67 | NADPH regeneration (GO:0006740) | 2.79322607 |
| 68 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.79129041 |
| 69 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.79129041 |
| 70 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.78799257 |
| 71 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.78050958 |
| 72 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.76641260 |
| 73 | type B pancreatic cell proliferation (GO:0044342) | 2.76610113 |
| 74 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.75810440 |
| 75 | negative regulation of ligase activity (GO:0051352) | 2.75810440 |
| 76 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.74504198 |
| 77 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.73701403 |
| 78 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.73701403 |
| 79 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.73701403 |
| 80 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.73237407 |
| 81 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.73237407 |
| 82 | galactose metabolic process (GO:0006012) | 2.71813464 |
| 83 | regulation of pseudopodium assembly (GO:0031272) | 2.69658773 |
| 84 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.68346108 |
| 85 | endothelial tube morphogenesis (GO:0061154) | 2.68259784 |
| 86 | morphogenesis of an endothelium (GO:0003159) | 2.68259784 |
| 87 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.66033490 |
| 88 | proline biosynthetic process (GO:0006561) | 2.65864841 |
| 89 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.65221399 |
| 90 | epithelial cell-cell adhesion (GO:0090136) | 2.63737542 |
| 91 | establishment of protein localization to plasma membrane (GO:0090002) | 2.60398495 |
| 92 | actin filament depolymerization (GO:0030042) | 2.59377741 |
| 93 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.58943881 |
| 94 | intestinal epithelial cell development (GO:0060576) | 2.58678827 |
| 95 | negative regulation of cell fate specification (GO:0009996) | 2.58425071 |
| 96 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.58132253 |
| 97 | regulation of cardioblast differentiation (GO:0051890) | 2.57287606 |
| 98 | barbed-end actin filament capping (GO:0051016) | 2.54513922 |
| 99 | extracellular fibril organization (GO:0043206) | 2.53380395 |
| 100 | cellular copper ion homeostasis (GO:0006878) | 2.51692540 |
KRT19P1 
